Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA‐3 Results

BACKGROUND. The efficacy and safety of palbociclib, a cyclin‐dependent kinase 4/6 inhibitor, combined with fulvestrant and goserelin was assessed in premenopausal women with advanced breast cancer (ABC) who had progressed on prior endocrine therapy (ET). PATIENTS AND METHODS. One hundred eight preme...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Loibl, Sibylle, Turner, Nicholas C., Ro, Jungsil, Cristofanilli, Massimo, Iwata, Hiroji, Im, Seock‐Ah, Masuda, Norikazu, Loi, Sherene, André, Fabrice, Harbeck, Nadia, Verma, Sunil, Folkerd, Elizabeth, Puyana Theall, Kathy, Hoffman, Justin, Zhang, Ke, Bartlett, Cynthia Huang, Dowsett, Mitchell
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2017
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599195/
https://ncbi.nlm.nih.gov/pubmed/28652278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0072
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados